课题基金 / 基金详情

Investigation into the mechanism for expansion of abnormal clone in paroxysmal nocturnal hemoglobinuria

Investigation into the mechanism for expansion of abnormal clone in paroxysmal nocturnal hemoglobinuria
阵发性睡眠性血红蛋白尿症异常克隆扩增机制的探讨
批准号:
16590940
负责人:
MURAKAMI Yoshiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

MURAKAMI Yoshiko的其他基金

相似基金

相关文献

中文摘要
翻译
探讨GPI阴性造血干细胞良性肿瘤样增殖的机制我们分析了两例PNH患者,他们表现出完全扩增的GPI缺陷克隆,具有相似的染色体异常。高迁移率族蛋白A2(HMGA 2)定位于断点处,并且在两个患者中HMGA 2的3' UTR被截短(我们未发表的数据)。截短形式的HMGA 2在肿瘤组织中异位表达,在正常状态下不表达,并使细胞像良性肿瘤一样生长。我们认为,异位表达的截短HMGA 2或上调该靶基因与PIG-A突变一起导致GPI缺陷干细胞的扩增。事实上,HMGA 2仅在两名患者的骨髓细胞的GPI阴性群体中高度表达。然而,与正常个体相比,包括上述两名患者在内的PNH患者的外周血细胞中HMGA 2表达没有显著上调。我们将进一步分析骨髓样本中HMGA 2的表达。我们也已经制造了HMGA 2截短型的转基因小鼠,并且已经证实其在骨髓细胞中表达,因此我们计划研究其与PNH细胞克隆扩增的关系。我们已经克隆了PIG-Y,它是GPI生物合成的第一步酶复合物的重要组成部分。PIG-Y是酵母Eri 1 p的同源物,但在酵母系统中未检测到PIG-Y与Ras家族蛋白活性形式的相互作用。
英文摘要
Investigation into the mechanism for the benign tumor like proliferation of GPI negative hematopoietic stem cells.We have analyzed two PNH patients who showed fully expanded GPI-deficient clones with similar chromosomal abnormalities. The high-mobility group protein A2 (HMGA2) is localized at the breakpoint and 3' UTR of HMGA2 is truncated in both patients (our unpublished data). The truncated form of HMGA2 is ectopically expressed in tumor tissues, unexpressed in normal state, and making cells grow like a benign tumor. We suggest that ectopic expression of this truncated HMGA2 or up-regulation of this target gene together with a PIG-A mutation result in expansion of GPI-deficient stem cells. In fact, HMGA2 was highly expressed only in the GPI negative populations of the bone marrow cells in both patients. However, HMGA2 expression was not significantly up-regulated in the peripheral blood cells in PNH patients including two patients mentioned above compared to normal individuals. We will further analyze the HMGA2 expression in the bone marrow samples. We have also made the transgenic mice of truncated form of HMGA2 and already confirmed its expression in bone marrow cells, so we are planning to investigate its relation to clonal expansion of PNH cells.We have cloned PIG-Y, which is important for the first step enzyme complex in GPI biosynthesis. PIG-Y is the homologue of Eri1p of yeast, but we could not detect the interactions between PIG-Y and active form of Ras family proteins, which was proved in yeast system.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Mammalian PIG-X and yeast Pbnlp are the essential glycosylphosphatidylinositol-mannosyltransferase I.
哺乳动物 PIG-X 和酵母 Pbnlp 是必需的糖基磷脂酰肌醇-甘露糖基转移酶 I。
DOI: --
发表时间: 2005
期刊: Mol.Biol.Cell 16
影响因子: --
作者: [Ashida, H.]
通讯作者: H.
Mammalian PIG-X and yeast Phn1p are the essential glycosylphosphatidylinositol-mannosyltransferase I.
哺乳动物 PIG-X 和酵母 Phn1p 是必需的糖基磷脂酰肌醇-甘露糖基转移酶 I。
DOI: --
发表时间: 2005
期刊: Mol.Biol.Cell 16
影响因子: --
作者: [Ashida, H.]
通讯作者: H.
Enhanced responses of glycosylphosphatidylinositol anchor-deficient T lymphocytes
糖基磷脂酰肌醇锚缺陷 T 淋巴细胞的增强反应
DOI: --
发表时间: 2004
期刊: J.Immunol. 173
影响因子: --
作者: [Hazenbos, W.L.W.]
通讯作者: W.L.W.
DOI: 10.1091/mbc.e05-08-0743
发表时间: 2005-11-01
期刊: MOLECULAR BIOLOGY OF THE CELL
影响因子: 3.3
作者: [Murakami, Y, Siripanyaphinyo, U, Kinoshita, T]
通讯作者: Kinoshita, T
Analysis for the molecular mechanism of Inheited GPI Deficiency
  • 批准号:
    23590363
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2011
  • 负责人:
    MURAKAMI Yoshiko
  • 依托单位:
Investigation of the mechanism for clonal expansion of GPI negative cells in paroxysmal nocturnal hemoglobinuria
  • 批准号:
    18591060
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.57万
  • 财政年份:
    2006
  • 负责人:
    MURAKAMI Yoshiko
  • 依托单位:
国内基金
海外基金
CircSKA3通过抑制HMGA2泛素化降解调控巨噬细胞M2型分化促进卵巢癌转移的机制研究
  • 批准号:
    QN25H160107
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    邓静雯
  • 依托单位:
Fra-1通过转录激活胃癌细胞HMGA2表达调控巨噬细胞极化的机制研究
  • 批准号:
    2025JJ80863
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    许娟
  • 依托单位:
HMGA2介导TMAO抑制结直肠癌细胞铁死亡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    蒋海忠
  • 依托单位:
XPA结合蛋白2通过HMGA2可变剪接影响卵巢癌铂耐药的机制研究
  • 批准号:
    2025JJ70423
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    田焱
  • 依托单位: